Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127487431 | 12748743 | 1 | I | 201606 | 20160906 | 20160915 | 20160915 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-58418BP | BOEHRINGER INGELHEIM | 80.37 | YR | F | Y | 0.00000 | 20160915 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127487431 | 12748743 | 1 | PS | COMBIVENT | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | Respiratory (inhalation) | DOSE PER APPLICATION: 20 MCG / 100 MCG; FORMULATION: INHALATION SPRAY | N | 21747 | PRESSURISED INHALATION | QID | |||||||
| 127487431 | 12748743 | 2 | SS | COMBIVENT | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | Respiratory (inhalation) | DOSE PER APPLICATION: 20 MCG / 100 MCG; FORMULATION: INHALATION SPRAY | N | 21747 | PRESSURISED INHALATION | TID | |||||||
| 127487431 | 12748743 | 3 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 20 MG | 0 | 20 | MG | TABLET | QD | ||||||
| 127487431 | 12748743 | 4 | C | Trentall | 2 | Oral | 1200 MG | 0 | 400 | MG | TABLET | TID | |||||||
| 127487431 | 12748743 | 5 | C | Lisinopril HCTZ | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | Oral | DOSE PER APPLICATION AND DAILY DOSE: 10/12.5MG | 0 | TABLET | QD | ||||||||
| 127487431 | 12748743 | 6 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG | 0 | 20 | MG | TABLET | QD | ||||||
| 127487431 | 12748743 | 7 | C | NIFEDIPINE. | NIFEDIPINE | 1 | Oral | 30 MG | 0 | 30 | MG | TABLET | QD | ||||||
| 127487431 | 12748743 | 8 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Oral | 5 MG | 0 | 5 | MG | TABLET | QD | ||||||
| 127487431 | 12748743 | 9 | C | Calcium with vitamin D | CALCIUMVITAMIN D | 1 | Oral | 0 | TABLET | ||||||||||
| 127487431 | 12748743 | 10 | C | MULTI-VITAMIN | .ALPHA.-TOCOPHEROL ACETATE, DL-ASCORBIC ACIDCYANOCOBALAMINFLUORIDE IONFOLIC ACIDNIACINPYRIDOXINERIBOFLAVINTHIAMINEVITAMIN AVITAMIN D | 1 | Oral | 1 ANZ | 0 | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127487431 | 12748743 | 1 | Chronic obstructive pulmonary disease |
| 127487431 | 12748743 | 3 | Blood cholesterol increased |
| 127487431 | 12748743 | 4 | Poor peripheral circulation |
| 127487431 | 12748743 | 5 | Hypertension |
| 127487431 | 12748743 | 6 | Gastrooesophageal reflux disease |
| 127487431 | 12748743 | 7 | Hypertension |
| 127487431 | 12748743 | 8 | Sleep disorder |
| 127487431 | 12748743 | 9 | Product used for unknown indication |
| 127487431 | 12748743 | 10 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127487431 | 12748743 | Productive cough |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127487431 | 12748743 | 1 | 201512 | 0 | ||
| 127487431 | 12748743 | 4 | 2000 | 0 | ||
| 127487431 | 12748743 | 5 | 2015 | 0 | ||
| 127487431 | 12748743 | 7 | 2001 | 0 |